$1.94 Billion is the total value of AMERICAN CAPITAL MANAGEMENT INC's 73 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 11.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IDXX | Sell | IDEXX Laboratories | $107,727,000 | +11.5% | 494,297 | -2.1% | 5.56% | +1.0% |
| ILMN | Sell | Illumina | $70,661,000 | +17.5% | 253,003 | -0.6% | 3.65% | +6.5% |
| MANH | Sell | Manhattan Associates | $63,417,000 | +12.1% | 1,349,002 | -0.1% | 3.28% | +1.6% |
| GNTX | Sell | Gentex | $55,084,000 | -0.7% | 2,392,874 | -0.7% | 2.84% | -10.0% |
| JKHY | Sell | Jack Henry & Associates | $50,645,000 | +7.7% | 388,500 | -0.1% | 2.62% | -2.4% |
| HOLX | Sell | Hologic | $47,098,000 | +6.2% | 1,184,850 | -0.2% | 2.43% | -3.7% |
| ACXM | Sell | Acxiom | $32,548,000 | +29.8% | 1,086,755 | -1.6% | 1.68% | +17.6% |
| FELE | Sell | Franklin Electric | $21,343,000 | +10.6% | 473,247 | -0.1% | 1.10% | +0.2% |
| HAE | Sell | Haemonetics | $21,003,000 | +18.4% | 234,200 | -3.4% | 1.08% | +7.4% |
| CSGP | Sell | Costar Group | $19,904,000 | +12.5% | 48,238 | -1.1% | 1.03% | +2.0% |
| DORM | Sell | Dorman Products | $18,678,000 | -10.8% | 273,427 | -13.5% | 0.96% | -19.1% |
| ZBRA | Sell | Zebra Technologies | $16,177,000 | -26.5% | 112,930 | -28.6% | 0.84% | -33.5% |
| MMSI | Sell | Merit Medical Systems | $14,233,000 | +12.5% | 277,995 | -0.4% | 0.74% | +1.9% |
| BCPC | Sell | Balchem | $10,051,000 | +20.0% | 102,410 | -0.0% | 0.52% | +8.8% |
| FORR | Sell | Forrester Research | $6,609,000 | -2.8% | 157,550 | -3.9% | 0.34% | -11.9% |
| NUVA | Sell | NuVasive | $6,592,000 | -7.0% | 126,485 | -6.8% | 0.34% | -15.8% |
| FWRD | Sell | Forward Air | $3,867,000 | -5.0% | 65,460 | -15.0% | 0.20% | -13.8% |
| WMGI | Sell | Wright Medical Group N.V. | $3,516,000 | +29.7% | 135,428 | -0.9% | 0.18% | +18.2% |
| FAST | Sell | Fastenal | $3,435,000 | -14.7% | 71,378 | -3.2% | 0.18% | -22.7% |
| AZPN | Sell | Aspen Technology | $2,581,000 | +16.3% | 27,831 | -1.1% | 0.13% | +5.6% |
| PAYX | Sell | Paychex | $2,168,000 | +9.9% | 31,723 | -1.0% | 0.11% | 0.0% |
| GLOB | Sell | Globant S.A. | $291,000 | -47.5% | 5,126 | -52.3% | 0.02% | -53.1% |
| FNGN | Sell | Financial Engines | $234,000 | -94.7% | 5,205 | -95.9% | 0.01% | -95.2% |
| CPSI | Sell | Computer Programs & Systems | $242,000 | +6.6% | 7,350 | -5.4% | 0.01% | -7.7% |
| IDSY | Exit | ID Systems | $0 | – | -20,570 | -100.0% | -0.01% | – |
| NTUS | Exit | Natus Medical | $0 | – | -8,965 | -100.0% | -0.02% | – |
| SCOR | Exit | ComScore | $0 | – | -89,400 | -100.0% | -0.12% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-07-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IDEXX Laboratories | 42 | Q3 2023 | 7.5% |
| ICON PLC | 42 | Q3 2023 | 5.9% |
| Verint Systems | 42 | Q3 2023 | 4.2% |
| ANSYS | 42 | Q3 2023 | 3.6% |
| Costar Group | 42 | Q3 2023 | 2.6% |
| Blackbaud | 42 | Q3 2023 | 1.8% |
| Manhattan Assocs | 41 | Q3 2023 | 8.5% |
| Cognex | 41 | Q3 2023 | 6.5% |
| ResMed | 41 | Q3 2023 | 4.5% |
| FactSet Research System | 41 | Q3 2023 | 3.9% |
View AMERICAN CAPITAL MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Kornit Digital Ltd. | February 16, 2021 | 2,606,807 | 6.0% |
| ORASURE TECHNOLOGIES INC | February 16, 2021 | 4,308,685 | 6.0% |
View AMERICAN CAPITAL MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-03 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View AMERICAN CAPITAL MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.